Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2033

Conditions
Hypoxic-Ischemic Encephalopathy, NeonatalBrain Injuries, Hypoxic-Ischemic
Interventions
BIOLOGICAL

Wharton's jelly-derived mesenchymal stem cells

MSCs (1x10\^7 cells/kg) in 10 mL 0.9%normal saline administered intravenously within 10 days, postnatally after TH completion, every 24 h for 3 consecutive days

DRUG

0.9 % Normal Saline

0.9% normal saline 10 mL administered intravenously within 10 days, postnatally after TH completion, every 24 h for 3 consecutive days

Trial Locations (1)

10700

Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
collaborator

Siriraj Hospital

OTHER

lead

Mahidol University

OTHER

NCT07018739 - Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy | Biotech Hunter | Biotech Hunter